{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:13456"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:13456","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Understanding proline metabolism in hypoxic cancer cells","abstract":"To survive, cancer cells adapt their metabolism to sustain increased biomass production and bioenergetic demand as well as modulation of redox homeostasis. In addition, tumour proliferation often demands oxygen to the extent that the vasculature cannot supply, leading to tumor hypoxia. This condition selects for the most aggressive cancer clones, promoting increased metastasis, drug resistance and invasion. How cancer cells adapt their metabolism to survive at low oxygen tensions, and if this metabolic reprogramming contains targetable vulnerabilities is not completely understood. The aim of this thesis was to uncover metabolic vulnerabilities under low oxygen tensions, highlighting proline metabolism as a dysregulated pathway in hypoxic cancer cells.","abstract_html":"To survive, cancer cells adapt their metabolism to sustain increased biomass production and bioenergetic demand as well as modulation of redox homeostasis. In addition, tumour proliferation often demands oxygen to the extent that the vasculature cannot supply, leading to tumor hypoxia. This condition selects for the most aggressive cancer clones, promoting increased metastasis, drug resistance and invasion. How cancer cells adapt their metabolism to survive at low oxygen tensions, and if this metabolic reprogramming contains targetable vulnerabilities is not completely understood. The aim of this thesis was to uncover metabolic vulnerabilities under low oxygen tensions, highlighting proline metabolism as a dysregulated pathway in hypoxic cancer cells.","abstract_has_math":false,"creators":["Vettore, Lisa"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-07","date_published":"2023-07","updated_at":"2026-11-19T09:32:17Z","subjects":["QH301 Biology","QH426 Genetics","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000183965358"],"render_values":[{"text":"0000-0001-8396-5358","href":"https://orcid.org/0000-0001-8396-5358","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/13456/7/Vettore2023PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A13456","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["cancer_research_uk","wellcome_trust"]},{"key":"dc:creator","label":"Author","values":["Vettore, Lisa"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000183965358"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-07-14"]},{"key":"dc:date.issued","label":"Date","values":["2023-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Metabolism and Systems Research"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/13456/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QH301 Biology","QH426 Genetics","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/13456/7/Vettore2023PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["To survive, cancer cells adapt their metabolism to sustain increased biomass production and bioenergetic demand as well as modulation of redox homeostasis. In addition, tumour proliferation often demands oxygen to the extent that the vasculature cannot supply, leading to tumor hypoxia. This condition selects for the most aggressive cancer clones, promoting increased metastasis, drug resistance and invasion. How cancer cells adapt their metabolism to survive at low oxygen tensions, and if this metabolic reprogramming contains targetable vulnerabilities is not completely understood. The aim of this thesis was to uncover metabolic vulnerabilities under low oxygen tensions, highlighting proline metabolism as a dysregulated pathway in hypoxic cancer cells."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Understanding proline metabolism in hypoxic cancer cells"]}]}],"canonical_facts":{"dc:contributor.sponsor":["cancer_research_uk","wellcome_trust"],"dc:creator":["Vettore, Lisa"],"dc:date":["2023-07-14"],"dc:date.issued":["2023-07"],"dc:description.abstract":["To survive, cancer cells adapt their metabolism to sustain increased biomass production and bioenergetic demand as well as modulation of redox homeostasis. In addition, tumour proliferation often demands oxygen to the extent that the vasculature cannot supply, leading to tumor hypoxia. This condition selects for the most aggressive cancer clones, promoting increased metastasis, drug resistance and invasion. How cancer cells adapt their metabolism to survive at low oxygen tensions, and if this metabolic reprogramming contains targetable vulnerabilities is not completely understood. The aim of this thesis was to uncover metabolic vulnerabilities under low oxygen tensions, highlighting proline metabolism as a dysregulated pathway in hypoxic cancer cells."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/13456/7/Vettore2023PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Metabolism and Systems Research"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/13456/"],"dc:subject":["QH301 Biology","QH426 Genetics","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"dcterms:accessrights":["public"],"dc:title":["Understanding proline metabolism in hypoxic cancer cells"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000183965358"]},"updated_at":"2026-11-19T09:32:17Z"}